4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Lung Neoplasms in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (10.34) | 18.2507 |
2000's | 13 (44.83) | 29.6817 |
2010's | 12 (41.38) | 24.3611 |
2020's | 1 (3.45) | 2.80 |
Authors | Studies |
---|---|
Boo, HJ; Jang, HJ; Kang, YP; Kwon, SW; Lee, HY; Min, HY | 1 |
Maser, E; Neumann, KT; Stapelfeld, C | 1 |
Balbo, S; Hecht, SS; Johnson, CS; Kovi, RC; O'Sullivan, MG | 1 |
Ashmore, JH; Lazarus, P; Luo, S; Watson, CJW | 1 |
Brookmeyer, C; Carmella, SG; Hecht, SS; Ming, X; Olvera, N; Yoder, A | 1 |
Ding, X; Liu, Z; Megaraj, V; Xie, F; Yang, W; Zhou, X | 1 |
Butler, LM; Hecht, SS; Stepanov, I; Yuan, JM | 1 |
Balbo, S; Hecht, SS; James-Yi, SA; Johnson, CS; Khariwala, SS; Kovi, RC; Le, CT; O'Sullivan, MG; Upadhyaya, P; Wang, M | 1 |
Carmella, SG; Derby, KS; Hatsukami, D; Hecht, SS; Le Marchand, L; Murphy, SE; Tiirikainen, M; Wang, H | 1 |
Anderson, KE; Benoit, AR; Caporaso, NE; Carmella, SG; Church, TR; Geisser, MS; Hecht, SS; Le, CT; Zhang, Y | 1 |
Carmella, SG; Fan, Y; Gao, YT; Han, S; Hecht, SS; Koh, WP; Murphy, SE; Wang, R; Wickham, K; Yu, MC; Yuan, JM | 1 |
Caberto, C; Carmella, S; Cuthrell, K; Derby, KS; Hecht, SS; Le Marchand, L; Murphy, SE | 1 |
Bhat, SH; Blair, IA; Gelhaus, SL; Mesaros, C; Vachani, A | 1 |
Asomaning, K; Carmella, SG; Chen, F; Christiani, DC; Hecht, SS; Lin, X; Su, L; Ter-Minassian, M; Zhao, Y | 1 |
Carmella, SG; Chen, M; Davis, AB; Gao, YT; Han, S; Hecht, SS; Moy, KA; Murphy, SE; Nelson, HH; Tao, L; Wang, R; Yu, MC; Yuan, JM; Zhong, Y | 1 |
D'Agostino, J; Ding, X; Xie, F; Zhou, X | 1 |
Hecht, SS; Murphy, SE; Nelson, HH; Stepanov, I; Yuan, JM | 1 |
Carmella, SG; Fristad, A; Han, S; Hecht, SS; Yang, Y | 1 |
Doerge, DR; Fang, JL; Lazarus, P; Upadhyaya, P; Wiener, D | 1 |
Carmella, SG; Hatsukami, DK; Hecht, SS; Jensen, J; Kramarczuk, I; Le, C; Li, YS; Losey, L; Murphy, SE; Puumala, SS; Roe, MR; Zimmerman, CL | 1 |
Hecht, SS | 2 |
Carmella, SG; Hatsukami, DK; Hecht, SS; Lemmonds, C; Murphy, S; Tulunay, OE; Zhang, Y | 1 |
Hecht, SS; Kassie, F; Lao, Y; Villalta, PW; Yu, N | 1 |
Chase, GA; Dyer, AM; Gallagher, CJ; Hicks, AN; Lazarus, P; Muscat, JE; Richie, J; Zheng, Y | 1 |
Behr, M; Ding, X; Fang, C; Kaminsky, LS; Turesky, RJ; Weng, Y | 1 |
Akerkar, SA; Borukhova, A; Carmella, SG; Chung, FL; Hecht, SS; Richie, JP; Skowronski, L | 1 |
Castonguay, A; Donnelly, PJ; Massey, TE; Petsikas, D; Reid, KR; Smith, GB | 1 |
Cole, SP; Deeley, RG; Hecht, SS; Ito , K; Leslie, EM; Upadhyaya, P | 1 |
3 review(s) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Lung Neoplasms
Article | Year |
---|---|
Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer.
Topics: Biomarkers; Carcinogens; Cotinine; Glucuronides; Humans; Lung Neoplasms; Mass Spectrometry; Multivariate Analysis; Nicotiana; Nicotine; Nitrosamines; Phenanthrenes; Polycyclic Aromatic Hydrocarbons; Prospective Studies; Pyridines; Risk; Risk Assessment; Smoke | 2014 |
Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke.
Topics: Air Pollutants; Benzene; Biomarkers, Tumor; Carcinogens; Environmental Exposure; Female; Humans; Hydrocarbons, Aromatic; Lung Neoplasms; Male; Nitrosamines; Pyridines; Risk Factors; Tobacco Smoke Pollution | 2004 |
Chemoprevention by isothiocyanates.
Topics: Animals; Anticarcinogenic Agents; Biotransformation; Carcinogens; Humans; Inactivation, Metabolic; Isothiocyanates; Lung Neoplasms; Mice; Nitrosamines; Rats | 1995 |
1 trial(s) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Lung Neoplasms
Article | Year |
---|---|
Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
Topics: Adult; Aged; Alkaloids; Biomarkers, Tumor; Carcinogens; Cotinine; Female; Glucuronates; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosamines; Pyridines; Research Design; Smoking; Smoking Cessation; Treatment Outcome | 2004 |
25 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Lung Neoplasms
Article | Year |
---|---|
Effect of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and benzo[a]pyrene exposure on the development of metabolic syndrome in mice.
Topics: 1-Butanol; Animals; Benzo(a)pyrene; Blood Glucose; Carcinogens; Humans; Lung Neoplasms; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Nitrosamines | 2023 |
Different inhibitory potential of sex hormones on NNK detoxification in vitro: A possible explanation for gender-specific lung cancer risk.
Topics: Carcinogens; Female; Gonadal Steroid Hormones; Humans; Liver; Lung Neoplasms; Male; Nicotiana; Nitrosamines; Pyridines; Sex Factors; Smoking; Tumor Cells, Cultured | 2017 |
Metastasis to the F344 Rat Pancreas from Lung Cancer Induced by 4-(Methylnitrosamino)- 1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)- 1-butanol, Constituents of Tobacco Products.
Topics: Animals; Carcinogens; Carcinoma; Lung Neoplasms; Male; Nicotiana; Nitrosamines; Pancreatic Neoplasms; Rats; Rats, Inbred F344; Stereoisomerism | 2018 |
Carbonyl reduction of NNK by recombinant human lung enzymes: identification of HSD17β12 as the reductase important in (R)-NNAL formation in human lung.
Topics: 17-Hydroxysteroid Dehydrogenases; Carcinogenesis; Carcinogens; Cytosol; Enzyme Assays; Gene Knockdown Techniques; HEK293 Cells; Humans; Lung; Lung Neoplasms; Microsomes; Nicotiana; Nitrosamines; Oxidation-Reduction; Recombinant Proteins; RNA, Small Interfering; Smoking; Stereoisomerism | 2018 |
High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.
Topics: Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Glucuronides; Humans; Lung Neoplasms; Nicotiana; Nitrosamines; Phenanthrenes; Polycyclic Aromatic Hydrocarbons; Pyridines; Smoke; Solid Phase Extraction; Tandem Mass Spectrometry | 2013 |
Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Carcinogens; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; DNA Adducts; Guanine; Humans; Lung Neoplasms; Mice, Transgenic; Microsomes; Nicotiana; Nitrosamines; Pyridines | 2014 |
Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.
Topics: Adenocarcinoma; Adenoma; Animals; Apoptosis; Carcinogens; Chromatography, High Pressure Liquid; DNA Adducts; DNA Damage; Humans; Lung Neoplasms; Male; Nitrosamines; Pancreatic Neoplasms; Prohibitins; Pyridines; Rats; Rats, Inbred F344; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism | 2014 |
Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine.
Topics: Adult; Aged; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nerve Tissue Proteins; Nicotine; Nitrosamines; Polymorphism, Single Nucleotide; Pyridines; Receptors, Nicotinic; Smoking | 2008 |
A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.
Topics: Aged; Biomarkers, Tumor; Case-Control Studies; Chi-Square Distribution; Female; Glucuronates; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Nicotiana; Nitrosamines; Prospective Studies; Pyridines; Risk Factors | 2009 |
Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.
Topics: Age Factors; Aged; Body Mass Index; Case-Control Studies; Cohort Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosamines; Prospective Studies; Pyridines; Smoking | 2009 |
Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
Topics: Aged; Asian; Carcinogens; Cross-Sectional Studies; Ethnicity; Female; Follow-Up Studies; Glucuronates; Hawaii; Humans; Inactivation, Metabolic; Lung Neoplasms; Male; Middle Aged; Nicotine; Nitrosamines; Prognosis; Pyridines; Risk Factors; Smoking; Survival Rate; White People | 2009 |
A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
Topics: Biomarkers, Tumor; Case-Control Studies; Chromatography, Liquid; Creatinine; DNA Adducts; Drug Stability; Humans; Isotope Labeling; Lung Neoplasms; Mass Spectrometry; Nitrosamines; Phenotype; Pyridines; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Smoking | 2011 |
Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adult; Aged; Case-Control Studies; Creatinine; Female; Humans; Individuality; Lung Neoplasms; Male; Middle Aged; Nicotine; Nitrosamines; Oxidoreductases; Polymorphism, Single Nucleotide; Pyridines; Smoking; Tobacco Smoke Pollution | 2012 |
Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers.
Topics: Aged; China; Cotinine; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nicotiana; Nicotine; Nitrosamines; Phenanthrenes; Prospective Studies; Pyridines; Smoke; Smoking | 2011 |
Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; Female; Lung; Lung Neoplasms; Mice; Mice, Knockout; Microsomes, Liver; Nitrosamines; Pyridines; Tissue Distribution | 2012 |
Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai cohort study.
Topics: Biomarkers; Cohort Studies; Cotinine; Esophageal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Nicotiana; Nitrosamines; Odds Ratio; Pyridines; Risk Factors; Smoking | 2013 |
Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
Topics: Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Humans; Lung Neoplasms; Nitrosamines; Pyridines; Sensitivity and Specificity; Smoking; Urinalysis | 2003 |
Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
Topics: Carcinogens; Cell Line; Chromatography, High Pressure Liquid; Glucuronides; Glucuronosyltransferase; Humans; In Vitro Techniques; Liver; Lung Neoplasms; Nitrosamines; Palatine Tonsil; Pyridines; Smoking; Tobacco, Smokeless | 2004 |
Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers.
Topics: Adolescent; Adult; Air Pollutants, Occupational; Biomarkers; Carcinogens; Cotinine; Creatinine; Female; Glucuronates; Humans; Interviews as Topic; Lung Neoplasms; Male; Middle Aged; Nicotine; Nitrosamines; Pyridines; Restaurants; Tobacco Smoke Pollution; Workforce | 2005 |
Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; DNA Adducts; Dose-Response Relationship, Drug; Lung Neoplasms; Male; Molecular Structure; Nitrosamines; Organ Specificity; Pyridines; Rats; Rats, Inbred F344; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Time Factors | 2007 |
The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer.
Topics: Adenocarcinoma; Biomarkers, Tumor; Case-Control Studies; Cross-Sectional Studies; Female; Florida; Gene Deletion; Genotype; Glucuronosyltransferase; Humans; Logistic Models; Lung Neoplasms; Male; New York; Nitrosamines; Phenotype; Pyridines; Risk; Smoking | 2007 |
Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice.
Topics: Animals; Carcinogens; Doxycycline; Female; Guanine; Inbreeding; Liver; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred A; Mice, Inbred C57BL; Mice, Transgenic; NADPH-Ferrihemoprotein Reductase; Nitrosamines; Pyridines | 2007 |
Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers.
Topics: Adult; Anticarcinogenic Agents; Carcinogens; Female; Follow-Up Studies; Glucuronates; Humans; Isothiocyanates; Lung Neoplasms; Male; Nitrosamines; Prognosis; Smoking; Vegetables | 1995 |
Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells.
Topics: Aged; Biotransformation; Carcinogens; Female; Humans; Hydroxylation; Inactivation, Metabolic; Lung; Lung Neoplasms; Macrophages, Alveolar; Male; Middle Aged; Nitrosamines; Oxidation-Reduction; Proadifen; Pulmonary Alveoli | 1999 |
Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog.
Topics: Animals; ATP-Binding Cassette Transporters; Biological Transport; Carcinogens; Cell Line; Cell Membrane; Dose-Response Relationship, Drug; Estradiol; Glutathione; HeLa Cells; Humans; Kinetics; Leukotriene C4; Lung Neoplasms; Mitochondrial Proteins; Models, Chemical; Multidrug Resistance-Associated Proteins; Nitrosamines; Rats; Ribosomal Proteins; Saccharomyces cerevisiae Proteins; Transfection | 2001 |